Posted on

Insurance denials for HCV therapy increase in U.S.

Healio– Despite the availability of highly effective direct-acting antiviral therapy for chronic hepatitis C virus infection, both public and private health insurers in the United States continue to deny coverage for the drugs at increasingly high rates, according to a...

Read More

Posted on

Patients’ Ability to Afford Lifesaving Drugs Is at Risk

U.S. News & World Report — Health insurers that want to discourage patients from choosing expensive medication therapies over less costly alternatives are targeting copay assistance programs, the coupons designed by drug manufacturers to help patients afford pricey medications their doctors...

Read More

Posted on

When insurers cut diabetes coverage

Arkansas Democrat-Gazette– Children with diabetes face a lifetime of challenges. And if insurers continue to exclude more and more diabetes-related medications and supplies from coverage, these children and their families could be saddled with a lifetime of exorbitant out-of-pocket costs...

Read More

Posted on

The Burnout Crisis in American Medicine

The Atlantic– During a recent evening on call in the hospital, I was asked to see an elderly woman with a failing kidney. She’d come in feeling weak and short of breath and had been admitted to the cardiology service...

Read More

12345...10...